In this pathway, MYC inhibits the expression level of MXI1 by affecting the expression of miR-155 and miR-23a, and MXI1 can also inhibit the expression level of MYC, thus forming a feedback loop to regulate glioma tumorigenesis and cell proliferation. The gene discussed is MXI1; the disease is central nervous system cancer.